Grand Rounds Webinar: “Oops, I did it again”: TMS as a Tool to Promote Sobriety and Decrease Drug and Alcohol Relapse
January 7, 2025 @ 8:00 pm - 9:00 pm
> >Register Now <<
Join the Clinical TMS Society for this installment of our Grand Rounds Webinar Series: "Oops, I did it again": TMS as a Tool to Promote Sobriety and Decrease Drug and Alcohol Relapse.
Speaker: Colleen A. Hanlon, PhD
Join us for an insightful session on Transcranial Magnetic Stimulation (TMS) as an innovative treatment for addiction. This session will explore the FDA approved use of TMS for smoking cessation, European clearance for stimulant use disorder, and emerging evidence supporting its application in alcohol use disorders. Learn about the mechanisms of action, current clinical research, and practical strategies for integrating TMS into your addiction treatment protocols. Designed for physicians and mental health providers, this session will provide valuable insights into how TMS can enhance patient outcomes and expand treatment options for substance use disorders.
At the end of the presentation, attendees will:
- Identify the current FDA indication for TMS in smoking cessation and discuss the emerging evidence supporting its use in stimulant and alcohol use disorders.
- Describe the mechanisms of action of TMS in the treatment of addiction and how it modulates brain activity to reduce substance use.
- Evaluate the mechanisms of action of TMS in the treatment of addiction and how it modulates brain activity to reduce substance use.
Take advantage of our live Q&A session at the conclusion of the webinar.
*Registered attendees will receive access to the on-demand video recording by Friday, January 10, 2025. You will receive an email notification with instructions on accessing the video. You may register for the on-demand webinar any time after the live webinar.
When:
USA - January 7, 2025 at 8:00pm EST | 5:00pm PST
UK- January 8, 2025 at 1:00am GMT
Australia- January 8, 2025 at 12:00pm AEDT
Cost:
Member: $25
Trainee Member: FREE
Non-Member: $50
All Grand Rounds are recorded and available On-Demand. Recordings are available by the Friday after the live event.
> >Register Now <<
About the Speaker: Colleen A. Hanlon, PhD
Vice President, Medical Affairs, BrainsWay
Professor (adjunct), Wake Forest University School of Medicine
Dr. Hanlon is an internationally recognized thought-leader in the development and expansion of non-invasive neuromodulation therapeutics for new populations.
She is currently serving as the Vice President of Medical Affairs for BrainsWay and Director of their Innovation Team. Before coming to BrainsWay she was a tenured professor at the Wake Forest School of Medicine. There she ran a multidisciplinary research program devoted to developing brain-circuit based interventions for individuals struggling with drug and alcohol use disorders. She has nearly 20 years of clinical research experience in transcranial magnetic stimulation (TMS) and brain imaging. Recognized as a pioneer int TMS for addiction, Dr. Hanlon received over $12 million in National Institute of Health funding, led over 15 clinical studies of TMS, published over 100 peer-reviewed publications, and mentored over 75 trainees in brain imaging and TMS.
She received her undergraduate degree from the University of Florida, a Ph.D. in neurobiology from Duke University wherein she focused on motor recovery after stroke and in Parkinsons Disease using functional MRI. She did a postdoctoral fellowship at Wake Forest University wherein she first became interested in neuromodulation.
In 2023, she was given the prestigious International Brain Stimulation Early Career Investigator award and she is the senior author on the first “Consensus Paper” published by a group of over 70 scientists from over 10 countries outlining the path forward for Non-Invasive Therapeutic Development for Addiction.
In addition to advancing the science and evidence for TMS for various indications, she also participates in the research training and education community at local, national, and international levels. She has directed the Advanced TMS Training Course sponsored by the National Center for Neuromodulation for Rehabilitation and has served on the grassroots Advocacy committee and Public Policy committees of several scientific organizations devoted to expanding access to care for individuals with drug and alcohol use disorders.